respiratory
Pulmonary fibrosis

Idiopathic pulmonary fibrosis therapeutics coming of age: ATS 2016


Dr Marilyn Glassberg recently attended the American Thoracic Society’s 2016 International Conference alongside 15,000 other pulmonary, critical care, and sleep researchers. She talks more about the conference in this blog, focusing particularly on idiopathic pulmonary fibrosis. My specific area of interest is idiopathic pulmonary fibrosis (IPF), an incurable and fatal disease characterized by a progressive ...

Already a member?

Enter your email to keep reading.


OR